SEC 13F Intelligence

Eagle Ridge Investment Management / ABBV

Eagle Ridge Investment Management’s Abbvie Inc Position

Does Eagle Ridge Investment Management own Abbvie Inc (ABBV)? Yes69.6K shares worth $12M (+1.08% of its 13F portfolio) as of Q4 2024, up from 69.3K shares the prior filed quarter.

Position Value
$12M
Q4 2024
Shares
69.6K
% of Portfolio
+1.08%
Quarters Held
25
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $9MQ4 ’18Q1 ’19: $8MQ2 ’19: $7MQ3 ’19: $8MQ4 ’19: $9MQ4 ’19Q1 ’20: $7MQ2 ’20: $9MQ3 ’20: $8MQ4 ’20: $9MQ4 ’20Q1 ’21: $8MQ2 ’21: $9MQ3 ’21: $8MQ4 ’21: $10MQ4 ’21Q1 ’22: $12MQ2 ’22: $11MQ3 ’22: $10MQ4 ’22: $12MQ4 ’22Q1 ’23: $12MQ2 ’23: $10MQ3 ’23: $11MQ4 ’23: $11MQ4 ’23Q1 ’24: $13MQ2 ’24: $12MQ3 ’24: $14MQ4 ’24: $12MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202469.6K$12M+1.08%
Q3 202469.3K$14M+1.20%
Q2 202469.3K$12M+1.10%
Q1 202470.4K$13M+1.18%
Q4 202371.6K$11M+1.09%
Q3 202371.6K$11M+1.16%
Q2 202372.3K$10M+1.02%
Q1 202372.6K$12M+1.30%
Q4 202273.5K$12M+1.39%
Q3 202274.2K$10M+1.25%
Q2 202271.3K$11M+1.32%
Q1 202272.1K$12M+1.25%
Q4 202172.1K$10M+1.02%
Q3 202175.3K$8M+0.90%
Q2 202177.1K$9M+1.01%
Q1 202178.4K$8M+1.03%
Q4 202085.4K$9M+1.16%
Q3 202088.9K$8M+1.09%
Q2 202089.7K$9M+1.33%
Q1 202094.6K$7M+1.25%
Q4 201999.7K$9M+1.18%
Q3 201999.7K$8M+1.09%
Q2 2019101.7K$7M+1.07%
Q1 2019102.5K$8M+1.21%
Q4 2018102.8K$9M+1.61%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Eagle Ridge Investment Management’s full portfolio or all institutional holders of ABBV.